Skip to search formSkip to main contentSkip to account menu

Cosopt

Known as: Cosopt® 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (4)

TimololTimolol Maleatedorzolamidedorzolamide / Timolol

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
North American cost analysis of brand name versus generic drugs for the treatment of glaucoma
Background According to the World Health Organization, glaucoma is a leading cause of irreversible blindness worldwide. By 2020… 
Review
2017
Review
2017
COMBINATION OF BRIMONIDINE AND TIMOLOL FOR TOPICAL OPHTHALMIC USE ( 58 ) Field of Classification Search None
, 15 ( 1 ) . Data Sheet for Brimonidine , 2007 , 1 Page . Data Sheet for Timolol , 2007 , 1 Page . David , Robert et al… 
2013
2013
Intraocular Pressure-Reducing Effects After Treatment is Changed to Cosopt^|^reg; Monotherapy in Broadly Defined Primary Open-Angle Glaucoma or Ocular Hypertension
Purpose: We investigated the effectiveness of monotherapy with Cosopt in reducing intraocular pressure (IOP) in patients who… 
2011
2011
[Assessment of visual function under treatment with topical antiglaucoma agents and systemic vasodilators. Clinical study on glaucoma patients].
UNLABELLED The authors present some observations regarding the use of topical anti-glaucoma therapy and systemic vasodilators… 
2008
2008
Comparison of Safety and Efficacy of Brinzolamide/Timolol (AZARGATM) vs. COSOPT® in Patients With Open-Angle Glaucoma or Ocular Hypertension
2008
2008
A patient preference comparison of two fixed combinations, brinzolamide 10 mg/ml+timolol 5 mg/ml suspension and dorzolamide 20 mg/ml +timolol 5 mg/ml solution in patients with open-angle glaucoma or…
Purpose To assess patient preference and comfort of Brinzolamide 10 mg/ml+Timolol 5 mg/ml Suspension (Brinz/Tim) compared to… 
2007
2007
Short-term influence of antiglaucomatous medications on the ocular pulse amplitude (OPA) measured with the dynamic contour tonometer Pascal®
Purpose: To assess the short and medium-term influence of antiglaucomatous treatment on the OPA value by DCT. Methods… 
2006
2006
Effect of Dorzolamide–Timolol (Cosopt®) Co–Administered With Latanoprost (XalatanTm) or Dorzolamide–Timolol Alone in Patents With Open Angle Glaucoma or Ocular Hypertension Not Adequately Controlled…
2005
2005
Impacto econmico do custo de colrios no tratamento do glaucoma
ABSTRACT Purpose: To evaluate the daily cost of antiglaucoma eyedropsand the economic impact related to the minimal wage; to com… 
2005
2005
[IOP in rabbits after instillation of a mixture of the antiglaucomatic Cosopt and the aminoacid L-argininin HCL into the conjunctival sac].
OBJECTIVE The article documents results of experiments focused to influence the physiological IOP values after application of the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)